CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly

This study investigates cerebrospinal fluid biomarkers related to immune activation and Alzheimer's pathology as predictive tools for cognitive decline in older adults. The research uses established biomarker analysis to identify individuals at risk of developing cognitive impairment.